5-Lipoxygenase inhibitors – patent and literature activity during 2001 – 2004

By Pommery Nicole   Massingham Roy   Hénichart Jean-Pierre  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 13-26

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of PDE4: a review of recent patent literature

By Odingo Joshua O  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 773-787

Informa Healthcare

Access to resources Recommend Favorite

Novel FabH inhibitors: a patent and article literature review (2000 – 2012)

By Luo Yin   Yang Yu-Shun   Fu Jie   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1325-1336

Informa Healthcare

Access to resources Recommend Favorite

β-Lactamase inhibitors: a survey of the patent literature 2000 – 2004

By Phillips Oludotun A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 319-331

Informa Healthcare

Access to resources Recommend Favorite

Patent focus on cancer chemotherapeutics V. Angiogenesis agents: September 2001 – August 2002

By Connell Richard D  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1763-1782

Informa Healthcare

Access to resources Recommend Favorite